World's Best Scientists 2026 revealed!
Takanori Teshima

Takanori Teshima

D-Index & Metrics

Immunology

D-Index
77
Citations
23914
World Ranking
1809
National Ranking
67

Medicine

D-Index
77
Citations
24069
World Ranking
18364
National Ranking
590

Overview

Takanori Teshima is affiliated with Hokkaido University in Japan and has contributed extensively to the field of medicine. Their research spans several key subfields including hematology, oncology, immunology, infectious diseases, and genetics. The primary focus areas of their work include hematopoietic stem cell transplantation, CAR-T cell therapy research, lymphoma diagnosis and treatment, acute myeloid leukemia research, immune cell function and interaction, SARS-CoV-2 detection and testing, and acute lymphoblastic leukemia research.

The scientist has published a significant number of papers in some of the most relevant academic journals for their field. Frequent publication venues include:

  • Blood
  • International Journal of Hematology
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • Annals of Hematology

Co-authorship is an important aspect of their scholarly work, and frequent collaborators have included:

  • Junichi Sugita
  • Masahiro Onozawa
  • Daigo Hashimoto
  • Hideki Goto
  • Mutsumi Nishida

Among the notable papers associated with or relevant to their field are:

  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation, 2020, New England Journal of Medicine
  • Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study, 2021, The Lancet Oncology
  • Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial, 2021, Nature Medicine
  • Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva, 2020, Journal of Infection
  • Mass Screening of Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 Using Saliva, 2020, Clinical Infectious Diseases

Best Publications

  • Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

    Jonathan U Peled;Antonio L C Gomes;Sean M Devlin;Eric R Littmann

  • Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

    Unknown

  • Acute graft-versus-host disease does not require alloantigen expression on host epithelium

    Takanori Teshima;Rainer Ordemann;Pavan Reddy;Svetlana Gagin

  • Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.

    Unknown

  • TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells

    Yoshikane Kikushige;Takahiro Shima;Shin Ichiro Takayanagi;Shingo Urata

  • Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

    Stephen J. Schuster;Constantine S. Tam;Peter Borchmann;Nina Worel

  • Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

  • Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

    Cristina Toffalori;Laura Zito;Valentina Gambacorta;Michela Riba

  • Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.

    Yoshihiro Eriguchi;Shuichiro Takashima;Hideyo Oka;Sonoko Shimoji

  • Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

    James L.M. Ferrara;Andrew C. Harris;Joel K. Greenson;Thomas M. Braun

  • LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

    Kenneth R. Cooke;Armin Gerbitz;James M. Crawford;Takanori Teshima

  • Lactose drives Enterococcus expansion to promote graft-versus-host disease.

    C. K. Stein-Thoeringer;C. K. Stein-Thoeringer;C. K. Stein-Thoeringer;K. B. Nichols;K. B. Nichols;A. Lazrak;A. Lazrak;M. D. Docampo;M. D. Docampo

  • Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

    Geoffrey R. Hill;Kenneth R. Cooke;Takanori Teshima;James M. Crawford

  • Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease

    Ulrich A. Duffner;Yoshinobu Maeda;Kenneth R. Cooke;Pavan Reddy

  • Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia

    Geoffrey R. Hill;Takanori Teshima;Takanori Teshima;Armin Gerbitz;Luying Pan

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • The Pathophysiology of Acute Graft-versus-Host Disease

    James L. M. Ferrara;Kenneth R. Cooke;Takanori Teshima

  • Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.

    Sumio Iwasaki;Shinichi Fujisawa;Sho Nakakubo;Keisuke Kamada

  • Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

    Cornelius Schmaltz;Cornelius Schmaltz;Cornelius Schmaltz;Onder Alpdogan;Onder Alpdogan;Onder Alpdogan;Kirsten J. Horndasch;Kirsten J. Horndasch;Kirsten J. Horndasch;Stephanie J. Muriglan;Stephanie J. Muriglan;Stephanie J. Muriglan

  • Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    Saad Zafar Usmani;Fredrik Schjesvold;Albert Oriol;Lionel Karlin

  • Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

    Pavan Reddy;Takanori Teshima;Mark Kukuruga;Rainer Ordemann

  • IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation

    Takanori Teshima;Geoffrey R. Hill;Luying Pan;Yani S. Brinson

  • Keratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease

    Oleg I. Krijanovski;Geoffrey R. Hill;Geoffrey R. Hill;Geoffrey R. Hill;Kenneth R. Cooke;Kenneth R. Cooke;Kenneth R. Cooke;Takanori Teshima;Takanori Teshima;Takanori Teshima

Frequent Co-Authors

Koichi Akashi
Koichi Akashi Kyushu University
Toshihiro Miyamoto
Toshihiro Miyamoto Kyushu University
Mine Harada
Mine Harada Kyushu University
James L.M. Ferrara
James L.M. Ferrara Icahn School of Medicine at Mount Sinai
Yoshiyuki Niho
Yoshiyuki Niho Kyushu University
Pavan Reddy
Pavan Reddy Baylor College of Medicine
Mutsumi Nishida
Mutsumi Nishida University of the Ryukyus
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Kenneth R. Cooke
Kenneth R. Cooke Johns Hopkins University School of Medicine
Chen Liu
Chen Liu Yale University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Many professionals consider advancing their expertise through specialized nurse practitioner programs, such as finding the cheapest pmhnp certificate programs. These affordable options make it easier for students to balance education with work or other commitments.

Nurse practitioners with a Doctor of Nursing Practice (DNP) degree enjoy competitive salaries across the United States. If you are curious about compensation, it’s helpful to research how much do dnps make in different states before committing to a program or location.

Career mobility is also a key factor. For example, some registered nurses may wish to enhance their skills by obtaining acute care nurse practitioner certification, which can lead to specialized roles in intensive and critical care settings. This transition often requires focused study and clinical practice.

For those aiming to expedite their education journey, accelerated nurse practitioner program options provide a faster path to licensure and practice. These programs are ideal for individuals with prior nursing experience looking to advance quickly.

Best Scientists Citing Takanori Teshima

Trending Scientists

Recently Published Articles